|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-4.38/-1.50
|
企业价值
19.05M
|
资产负债 |
每股账面净值
8.92
|
现金流量 |
现金流量率
--
|
损益表 |
收益
2.04M
|
每股收益
0.17
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/05/01 04:14 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Dominari Holdings Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company's oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. |